IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.325
EU - Europa 29.443
AS - Asia 18.445
SA - Sud America 3.503
AF - Africa 1.182
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 88.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.772
GB - Regno Unito 7.345
RU - Federazione Russa 5.936
SG - Singapore 5.832
CN - Cina 5.496
IT - Italia 4.730
IE - Irlanda 2.967
BR - Brasile 2.905
VN - Vietnam 2.004
UA - Ucraina 1.667
HK - Hong Kong 1.576
FR - Francia 1.557
DE - Germania 1.549
SE - Svezia 1.423
FI - Finlandia 1.064
KR - Corea 987
ZA - Sudafrica 676
BD - Bangladesh 663
IN - India 520
NL - Olanda 307
CA - Canada 284
AR - Argentina 209
TR - Turchia 207
IQ - Iraq 191
JP - Giappone 186
PL - Polonia 186
MX - Messico 152
ES - Italia 143
PK - Pakistan 109
CI - Costa d'Avorio 104
EC - Ecuador 97
ID - Indonesia 97
AT - Austria 90
NG - Nigeria 83
CZ - Repubblica Ceca 78
KE - Kenya 78
VE - Venezuela 73
BE - Belgio 71
AU - Australia 66
UZ - Uzbekistan 65
MA - Marocco 61
SA - Arabia Saudita 60
CL - Cile 59
CH - Svizzera 58
CO - Colombia 53
IR - Iran 46
EG - Egitto 45
AE - Emirati Arabi Uniti 41
MY - Malesia 39
DZ - Algeria 37
NP - Nepal 37
JO - Giordania 34
PH - Filippine 34
LT - Lituania 33
PE - Perù 33
PY - Paraguay 28
TN - Tunisia 27
IL - Israele 26
KZ - Kazakistan 26
RO - Romania 25
JM - Giamaica 24
UY - Uruguay 24
GR - Grecia 22
DK - Danimarca 21
BG - Bulgaria 20
BY - Bielorussia 20
CR - Costa Rica 20
LB - Libano 20
AL - Albania 17
BO - Bolivia 16
ET - Etiopia 16
EU - Europa 16
HU - Ungheria 16
PT - Portogallo 16
AZ - Azerbaigian 15
PA - Panama 15
OM - Oman 14
SN - Senegal 14
EE - Estonia 13
LV - Lettonia 12
TW - Taiwan 12
BH - Bahrain 10
DO - Repubblica Dominicana 10
KG - Kirghizistan 10
PS - Palestinian Territory 10
SV - El Salvador 10
TH - Thailandia 10
CY - Cipro 9
HN - Honduras 9
AM - Armenia 8
RS - Serbia 8
BB - Barbados 7
GE - Georgia 7
HR - Croazia 7
LY - Libia 7
MK - Macedonia 7
NO - Norvegia 7
QA - Qatar 7
AO - Angola 6
BA - Bosnia-Erzegovina 6
Totale 88.865
Salva come PNG Salva come JPEG
Città #
Southend 6.689
Dallas 5.930
Singapore 3.515
Fairfield 3.337
Dublin 2.923
Ashburn 2.566
Santa Clara 1.763
Chandler 1.704
Moscow 1.632
Woodbridge 1.580
Hong Kong 1.489
Wilmington 1.357
Houston 1.344
Jacksonville 1.325
Hefei 1.294
San Jose 1.291
Seattle 1.271
Beijing 1.155
Cambridge 1.124
Seoul 970
Siena 859
Ann Arbor 840
The Dalles 673
Menlo Park 655
Los Angeles 653
Helsinki 628
Johannesburg 619
Ho Chi Minh City 594
New York 553
Milan 552
Princeton 536
Lauterbourg 508
Council Bluffs 494
Hanoi 486
Munich 459
Nanjing 454
Rome 292
Buffalo 281
São Paulo 268
Boardman 258
San Mateo 232
Florence 227
San Diego 205
Bengaluru 177
Düsseldorf 172
Dong Ket 161
Columbus 156
Orem 154
Chicago 148
Nanchang 141
London 138
Redondo Beach 136
Frankfurt am Main 135
Shenyang 126
Warsaw 120
Shanghai 113
Tokyo 109
Abidjan 104
Dearborn 100
Turku 100
Rio de Janeiro 94
Nuremberg 92
Lappeenranta 89
Toronto 86
Changsha 85
Tianjin 85
Chennai 83
Da Nang 83
Haiphong 82
Montreal 81
Abuja 80
Washington 79
Guangzhou 78
Brooklyn 76
San Francisco 75
Hebei 68
Baghdad 67
Jiaxing 67
Belo Horizonte 64
Naples 64
Denver 62
Stockholm 61
Jinan 60
Brussels 57
Amsterdam 56
Atlanta 56
Bologna 56
Izmir 56
Tashkent 55
Boston 53
Manchester 52
Kunming 51
Mexico City 51
Portsmouth 51
Venezia 51
Norwalk 50
Zhengzhou 47
Málaga 46
Phoenix 46
Olomouc 45
Totale 60.515
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 888
A first update on mapping the human genetic architecture of COVID-19 582
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 577
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 515
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 504
Genetic mechanisms of critical illness in COVID-19 430
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 418
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 404
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 372
An explainable model of host genetic interactions linked to COVID-19 severity 371
Antirheumatic agents in covid-19: is IL-6 the right target? 360
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 356
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 356
Pathogen-sugar interactions revealed by universal saturation transfer analysis 355
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 355
Antiangiogenic VEGF isoform in inflammatory myopathies 350
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 348
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 345
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 333
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 330
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 319
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 316
A case of amyloid myopathy in a patient with familial Mediterranean fever 315
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 314
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 314
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 314
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 313
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 312
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 310
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 303
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 302
Colchicine myopathy and neuromyopathy: two cases with different characteristics 298
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 294
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 294
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 293
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 292
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 291
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 290
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 287
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 285
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 284
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 284
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 282
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 271
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 271
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 271
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 270
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 269
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 264
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 263
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 262
Clodronate in the management of different musculoskeletal conditions 260
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 260
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 259
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 258
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 258
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 258
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 257
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 254
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 251
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 247
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 247
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 247
Autoinflammatory disorders and patients with isolated serosal involvement. 245
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 245
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 240
Weekly oral alendronate in mevalonate kinase deficiency 240
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 240
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 239
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 238
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 237
Recommendations for the management of autoinflammatory diseases 237
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 237
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 237
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 236
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 234
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 233
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 232
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 231
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 231
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 231
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 231
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 230
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 228
Clinical and biochemical landmarks in systemic autoinflammatory diseases 224
Biological treatments in Behçet's disease: beyond anti-TNF therapy 224
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 224
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 223
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 223
Untangling the Web of Systemic Autoinflammatory Diseases 221
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 221
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 219
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 219
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 218
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 217
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 217
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations 217
Totale 29.257
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 0 0 0 0 0 0 632
2021/20225.082 494 567 335 334 286 183 227 204 365 627 508 952
2022/20236.237 407 417 733 884 616 1.259 238 501 650 135 244 153
2023/20245.263 236 162 480 278 229 1.332 1.531 206 43 161 163 442
2024/202514.742 600 710 1.543 802 1.633 826 654 832 1.018 708 1.488 3.928
2025/202634.384 2.531 5.405 4.522 4.072 5.882 1.536 3.751 1.365 1.309 1.786 1.279 946
Totale 90.642